CSPC Innovation Pharmaceutical Co., Ltd. (SHE:300765)

SHE:300765 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Cash & Equivalents	1,299	872.08	3,770	2,196	1,244	1,139
Short-Term Investments	-	355.53	-	-	-	-
Trading Asset Securities	-	470.09	-	-	413.59	321.94
Cash & Short-Term Investments	1,299	1,698	3,770	2,196	1,658	1,461
Cash Growth	-51.70%	-54.97%	71.71%	32.43%	13.51%	1.77%
Accounts Receivable	611.54	559.76	560.78	716.75	508.94	303.96
Other Receivables	2.08	2.05	1.55	1.56	1.37	1.8
Receivables	613.62	561.81	562.32	718.31	510.31	305.76
Inventory	416.62	398.67	224.82	238.13	262	111
Other Current Assets	520.3	144.22	60.29	38.47	56.92	35.6
Total Current Assets	2,849	2,802	4,618	3,191	2,487	1,913
Property, Plant & Equipment	2,657	2,668	2,312	1,055	926.42	727.49
Long-Term Investments	276.95	264.45	267.07	253.49	243.19	235.87
Goodwill	-	-	-	-	-	3.47
Other Intangible Assets	223.63	225.21	231.59	50.42	52.81	55.21
Long-Term Deferred Tax Assets	21.99	21.61	17.36	18.88	12.5	10.39
Other Long-Term Assets	63.3	40.29	26.33	15.9	19.06	9.43
Total Assets	6,092	6,022	7,472	4,584	3,741	2,955
Accounts Payable	434.2	396.21	1,264	178.75	129.17	64.16
Accrued Expenses	27.41	64.59	66.11	66.24	54.57	25.1
Current Portion of Long-Term Debt	-	-	-	0.22	-	-
Current Portion of Leases	0.63	0.84	0.81	-	0.84	-
Current Income Taxes Payable	13.15	17.15	28.36	34.77	14.95	10.26
Current Unearned Revenue	21.35	18.68	19.8	68.26	30.37	25.27
Other Current Liabilities	1,109	936.82	524.42	234.52	178.75	109.46
Total Current Liabilities	1,606	1,434	1,904	582.77	408.64	234.24
Long-Term Debt	-	-	-	19.8	-	-
Long-Term Leases	-	-	0.84	-	-	-
Long-Term Unearned Revenue	126.78	90.49	84.16	37.21	34.27	33.31
Long-Term Deferred Tax Liabilities	1.73	1.4	0.02	0.06	0.67	0.45
Total Liabilities	1,735	1,526	1,989	639.84	443.58	268
Common Stock	1,405	1,405	1,171	618.93	546	420
Additional Paid-In Capital	979.32	977.27	2,125	1,138	1,211	882.28
Retained Earnings	1,640	1,667	1,988	2,177	1,533	1,376
Treasury Stock	-321.03	-321.03	-4.25	-	-	-
Comprehensive Income & Other	2.54	2.5	1.98	0.72	-1.2	-0.1
Total Common Equity	3,706	3,731	5,281	3,936	3,289	2,678
Minority Interest	651.9	765.39	202.45	8.59	8.26	8.79
Shareholders' Equity	4,358	4,496	5,483	3,944	3,298	2,687
Total Liabilities & Equity	6,092	6,022	7,472	4,584	3,741	2,955
Total Debt	0.63	0.84	1.65	20.02	0.84	-
Net Cash (Debt)	1,298	1,697	3,769	2,176	1,657	1,461
Net Cash Growth	-51.70%	-54.97%	73.21%	31.29%	13.45%	1.77%
Net Cash Per Share	0.93	1.21	2.70	1.63	1.24	1.24
Filing Date Shares Outstanding	1,393	1,393	1,405	1,337	1,179	1,179
Total Common Shares Outstanding	1,393	1,393	1,405	1,337	1,179	1,179
Working Capital	1,243	1,368	2,714	2,608	2,079	1,679
Book Value Per Share	2.66	2.68	3.76	2.94	2.79	2.27
Tangible Book Value	3,482	3,505	5,049	3,885	3,237	2,619
Tangible Book Value Per Share	2.50	2.52	3.59	2.91	2.74	2.22
Buildings	-	1,020	973.56	609.24	430.75	397.71
Machinery	-	1,939	1,821	925.79	701.65	475.66
Construction In Progress	-	620.23	228.71	70.74	294.97	154.83

Updated Mar 20, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.